| Primary |
| Tuberculin Test |
83.2% |
| Hypersensitivity |
2.9% |
| Mycobacterium Tuberculosis Complex Test |
2.1% |
| Tuberculosis |
1.8% |
| Tourette's Disorder |
1.4% |
| Tuberculosis Test |
1.4% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Blood Cholesterol Increased |
0.7% |
| Depression |
0.7% |
| Hypothyroidism |
0.7% |
| Skin Test |
0.7% |
| Antidepressant Therapy |
0.4% |
| Asthma |
0.4% |
| Cardiovascular Event Prophylaxis |
0.4% |
| Diabetes Mellitus |
0.4% |
| Dyspnoea |
0.4% |
| Food Allergy |
0.4% |
| Hypercholesterolaemia |
0.4% |
| Oral Contraception |
0.4% |
| Prenatal Care |
0.4% |
|
| Injection Site Induration |
19.6% |
| Injection Site Rash |
14.2% |
| False Positive Tuberculosis Test |
9.3% |
| Injection Site Warmth |
8.8% |
| Injection Site Erythema |
4.9% |
| Injection Site Pruritus |
4.4% |
| Rash Erythematous |
4.4% |
| Wrong Drug Administered |
4.4% |
| Injection Site Swelling |
3.9% |
| Incorrect Route Of Drug Administration |
2.9% |
| Pruritus |
2.9% |
| Accidental Exposure |
2.5% |
| Anaphylactic Reaction |
2.5% |
| No Adverse Drug Reaction |
2.5% |
| Pruritus Allergic |
2.5% |
| Tuberculosis Skin Test Positive |
2.5% |
| Hypersensitivity |
2.0% |
| Injection Site Reaction |
2.0% |
| Injection Site Vesicles |
2.0% |
| Pain In Extremity |
2.0% |
|
| Secondary |
| Tuberculin Test |
94.4% |
| Tuberculosis Test |
5.6% |
|
| Injection Site Induration |
26.7% |
| Application Site Reaction |
6.7% |
| False Positive Tuberculosis Test |
6.7% |
| Gait Disturbance |
6.7% |
| Injection Site Erythema |
6.7% |
| Injection Site Warmth |
6.7% |
| Localised Oedema |
6.7% |
| Pyrexia |
6.7% |
| Rash Erythematous |
6.7% |
| Rash Papular |
6.7% |
| Skin Exfoliation |
6.7% |
| Thyroid Disorder |
6.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.0% |
| Schizophrenia |
15.0% |
| Supplementation Therapy |
15.0% |
| Pulmonary Arterial Hypertension |
10.0% |
| Fatigue |
5.0% |
| Insomnia |
5.0% |
| Multiple Sclerosis |
5.0% |
| Muscle Spasticity |
5.0% |
| Pain |
5.0% |
| Somnolence |
5.0% |
| Tuberculin Test |
5.0% |
| Tuberculosis |
5.0% |
|
| Death |
57.1% |
| Injection Site Erythema |
14.3% |
| Progressive Multifocal Leukoencephalopathy |
14.3% |
| Psychotic Disorder |
14.3% |
|
